Form D · Other
Pathfinder Oncology, Inc.
Raleigh, NC · CIK 0002026800
Offering snapshot reported Jun 12, 2024 · SEC filing
- Reported sold
- $4M Offering amount: $6M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 30, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 12, 2024 | Initial | $4,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-515824
Source: Form D, filed Jun 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William Hoos | Director, Executive, Promoter |
Issuer details
Industry: Other (See others in industry)
Address:
2920 Forestville Road Suite 100 #3046
Raleigh, NC, 27616
Raleigh, NC, 27616